#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA620365	F	Inhibition of cell growth was studied in human teratocarcinoma (833K).	Homo sapiens	2		cell-based format	Scientific Literature
2.	ALA661953	F	Inhibition of cell growth was studied in chinese hamster lung cells (DC-3F)	Cricetulus griseus	2		cell-based format	Scientific Literature
3.	ALA662768	F	Inhibition of cell growth was studied in chinese hamster lung cells resistant to actinomycin D (DC-3F/AD-II).	Cricetulus griseus	2		cell-based format	Scientific Literature
4.	ALA695278	F	Inhibition of cell growth was studied in human promyelocytic leukemic (HL-60) cells.	Homo sapiens	4		cell-based format	Scientific Literature
5.	ALA731760	F	Anti cancer activity was tested on day 14, in mice bearing Lewis lung adenocarcinoma by injecting 0.4 mg/kg dose of compound intraperitoneally and a. average weight change was reported.	Mus musculus	1		organism-based format	Scientific Literature
6.	ALA728302	F	Anti cancer activity was tested on day 14, in mice bearing Lewis lung adenocarcinoma by injecting 0.8 mg/kg dose of compound intraperitoneally and average tumor volume was calculated.	Mus musculus	2		organism-based format	Scientific Literature
7.	ALA728303	F	Anti cancer activity was tested on day 7, in mice bearing Lewis lung adenocarcinoma by injecting 0.4 mg/kg dose of compound intraperitoneally and average tumor volume was calculated.	Mus musculus	2		organism-based format	Scientific Literature
8.	ALA728305	F	Anti cancer activity was tested on day10, in mice bearing Lewis lung adenocarcinoma by injecting 0.4 mg/kg dose of compound intraperitoneally and average tumor volume was calculated.	Mus musculus	2		organism-based format	Scientific Literature
9.	ALA728306	F	Anti cancer activity was tested on day10, in mice bearing Lewis lung adenocarcinoma by injecting 0.8 mg/kg dose of compound intraperitoneally and average tumor volume was calculated.	Mus musculus	2		organism-based format	Scientific Literature
10.	ALA728307	F	Anti cancer activity was tested on day 14, in mice bearing Lewis lung adenocarcinoma by injecting 0.4 mg/kg dose of compound intraperitoneally and a. average weight change was reported.	Mus musculus	1		organism-based format	Scientific Literature
11.	ALA733490	F	Anti cancer activity was tested on day 14, in mice bearing Lewis lung adenocarcinoma by injecting 0.8 mg/kg dose of compound intraperitoneally and average weight change was reported.	Mus musculus	2		organism-based format	Scientific Literature
12.	ALA733491	F	Anti cancer activity was tested on day 7, in mice bearing Lewis lung adenocarcinoma by injecting 0.4 mg/kg dose of compound intraperitoneally and average weight change was reported.	Mus musculus	2		organism-based format	Scientific Literature
13.	ALA733493	F	Anti cancer activity was tested on day10, in mice bearing Lewis lung adenocarcinoma by injecting 0.4 mg/kg dose of compound intraperitoneally and average weight change was reported.	Mus musculus	1		organism-based format	Scientific Literature
14.	ALA730820	F	Anti cancer activity was tested on day10, in mice bearing Lewis lung adenocarcinoma by injecting 0.8 mg/kg dose of compound intraperitoneally and average weight change was reported.	Mus musculus	2		organism-based format	Scientific Literature
15.	ALA806362	F	Inhibition of cell growth was studied in human mammary adenocarcinoma (SKBR-3).	Homo sapiens	2		cell-based format	Scientific Literature